Upcoming Workshops
Past Workshops
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- Chronic Lymphocytic Leukemia (CLL): Treatment Updates
- New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
- Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
- Adults Living with Acute Lymphocytic Leukemia (ALL): Treatment Updates
- Progress in the Treatment of Myelodysplastic Syndromes (MDS)
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Update from the 2021 American Society of Hematology (ASH) Annual Meeting
- Transplantation as a Treatment Option for Blood Cancers
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
- Update on CAR-T Cell Therapy
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Taking Your Blood Cancer Treatment on Schedule
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Treatment Update for Adults Living with Acute Lymphocytic Leukemia (ALL)
- New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)